EW
Edwards LifesciencesCNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Durable share gains in transcatheter and surgical valve franchises plus margin expansion from operational leverage and successful new-device adoption push the stock toward the high end of analyst targets within 12 months.
Posture
Mixed
Lead driver
Momentum
What changed
5 setup hits (3d) with net bullish as of 2026-06-02.
What can break
Procedure volume slowdown or macro-driven elective surgery declines
Momentum
62
Value
52
Sentiment
49
Setup hits (3d)
5 · Net Bullish
AI TargetsBase $95.00 · Bull $110.00 · Bear $76.80
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-12 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $96.97
Why
Momentum62 · Δ7d +2.8
Value52 · Δ7d -0.3
Sentiment49 · Δ7d +0.1
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
62
34% active weight
Current posture
7d trendSoftening
Δ7d
+2.8
Δ21d
+15.1
Value
52
32% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-0.3
Sentiment
49
33% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-6.9
Why this grade
Composite grade C. Momentum 62.1 / Value 51.9 / Sentiment 49.2
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$50.76B
Beta
0.94
Shares Out
580.3M
P/E (TTM)
36.9
P/S (TTM)
8.30
P/FCF (TTM)
61.09
Rev YoY
+14.7%
EPS YoY
-17.7%
Gross Margin
+78.2%
Op Margin
+23.4%
Net Debt
-$3.38B
Current Ratio
4.00
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology